Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05172609 · ClinicalTrials.gov registry record · NA
An Exposure-Based Implementation Strategy to Decrease Clinician Anxiety Around Suicide Prevention
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 42
- Enrollment target
NCT05172609: Completed NA study, sponsored by University of Pennsylvania.
NCT05172609 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 42 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05172609, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
Study Summary
Study objectives are to design and pilot test a novel, exposure-based implementation strategy (EBIS) directly targeting clinician anxiety and low self-efficacy for use of evidence-based suicide screening, assessment, and intervention (SSAI) strategies with patients at risk for suicide in community settings. Early phases of this study will develop the EBIS in partnership with community clinicians (n = 15). The last phase of this study is a pilot clinical trial in which 40 community mental health clinicians will be randomized to receive either implementation as usual (IAU) or IAU+EBIS.
Interventions
- BEHAVIORAL Exposure Based Implementation Strategy (EBIS)
- BEHAVIORAL Implementation as Usual (IAU)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2023-03-29 |
| Est. Completion | 2024-07-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05172609
The ClinicalTrials.gov registry entry for NCT05172609 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Exposure Based Implementation Strategy (EBIS) is the first listed.
NCT05172609 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05172609 about?
NCT05172609 is a clinical study titled "An Exposure-Based Implementation Strategy to Decrease Clinician Anxiety Around Suicide Prevention". Study objectives are to design and pilot test a novel, exposure-based implementation strategy (EBIS) directly targeting clinician anxiety and low self-efficacy for use of evidence-based suicide screening, assessment, and intervention (SSAI) strategies with patients at risk for suicide in community s...
What is the current status of trial NCT05172609?
This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2023-03-29. Estimated completion is 2024-07-29.
What interventions are being tested in trial NCT05172609?
The interventions under investigation include: Exposure Based Implementation Strategy (EBIS) (BEHAVIORAL), Implementation as Usual (IAU) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05172609?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.